跳转至内容
Merck
CN

D0600000

去乙酰毛花苷

European Pharmacopoeia (EP) Reference Standard

别名:

Deacetyllanatoside C, Desacetyllanatoside C

登录查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C47H74O19
化学文摘社编号:
17598-65-1
分子量:
943.08
MDL编号:
MFCD00135818
UNSPSC代码:
41116107
NACRES:
NA.24

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

等级

pharmaceutical primary standard

API类

deslanoside

制造商/商品名称

EDQM

应用

pharmaceutical (small molecule)

包装形式

neat

储存温度

2-8°C

SMILES字符串

O1CC(=CC1=O)[C@@H]2[C@@]3([C@@]([C@H]4[C@@H]([C@@]5([C@@H](C[C@H](CC5)O[C@@H]6O[C@@H]([C@H]([C@H](C6)O)O[C@@H]7O[C@@H]([C@H]([C@H](C7)O)O[C@@H]8O[C@@H]([C@H]([C@H](C8)O)O[C@@H]9O[C@@H]([C@H]([C@@H]([C@H]9O)O)O)CO)C)C)C)CC4)C)C[C@H]3O)(CC2)O)C

InChI

1S/C47H74O19/c1-20-41(64-36-16-30(50)42(21(2)60-36)65-37-17-31(51)43(22(3)61-37)66-44-40(56)39(55)38(54)32(18-48)63-44)29(49)15-35(59-20)62-25-8-10-45(4)24(13-25)6-7-27-28(45)14-33(52)46(5)26(9-11-47(27,46)57)23-12-34(53)58-19-23/h12,20-22,24-33,35-44,48-52,54-57H,6-11,13-19H2,1-5H3/t20-,21-,22-,24-,25+,26-,27-,28+,29+,30+,31+,32-,33-,35+,36+,37+,38-,39+,40-,41-,42-,43-,44+,45+,46+,47+/m1/s1

InChI key

OBATZBGFDSVCJD-LALPQLPRSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Deslanoside EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

象形图

Skull and crossbonesHealth hazard
GHS06,GHS08

警示用语：

Danger

危险声明

H301 + H331,H373

危险分类

Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - STOT RE 2

储存分类代码

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Topochemical examinations of the lungs of the rat after combined administration of serpasil and deslanatoside. I. Histochemical examinations.
E A Jedrzejewska
Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 42, 133-138 (1987-01-01)
[Positive inotropic effect of digitalis on the left ventricular systolic time interval in patients with primary dilated cardiomyopathy observed during increased heart ventricle load].
J P Dubiel et al.
Przeglad lekarski, 43(6), 433-438 (1986-01-01)
[Histoenzymatic studies of the kidneys of albino rats after experimental administration of serpasil and deslanoside].
A Zarebska
Patologia polska, 36(2), 200-207 (1985-04-01)
A Fronczak et al.
Polish journal of pharmacology and pharmacy, 41(6), 597-609 (1989-11-01)
4'-epidoxorubicin (4'-epiDXR) was compared with doxorubicin (DXR) for myocardial effects in rabbits. Histologically, both drugs when given for six weeks induced a high incidence of diffused myocardial damage. The myocardial damage was less evident in rabbits treated with 4'-epiDXR than
Wayne L Miller et al.
European journal of heart failure, 4(1), 63-72 (2002-01-29)
Digitalis has a long history in the treatment of heart failure but its effects on cardiac hemodynamics and neurohormonal modulation are not well characterized. The purpose of this study was to evaluate the relationship between atrial natriuretic peptide (ANP) and
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持